Anaptysbio (ANAB) Non-Current Debt (2016 - 2018)
Anaptysbio (ANAB) reported Non-Current Debt of $625000.0 for Q4 2018, down 91.73% on a YoY basis from $7.6 million in Q4 2017, and down 74.06% quarter-over-quarter from $2.4 million in Q3 2018.
Anaptysbio (ANAB) Non-Current Debt (2016 - 2018) Analysis & Trends
Anaptysbio has reported Non-Current Debt for 3 years, with the latest figure at $625000.0 in Q4 2018.
- For the quarter ending Q4 2018, Non-Current Debt fell 91.73% year-over-year to $625000.0; the trailing twelve-month figure through Dec 2018 stood at $625000.0 (down 91.73% YoY), and the FY2018 full-year result was $625000.0, down 91.73% from the prior year.
- Non-Current Debt for Q4 2018 stood at $625000.0, down from $2.4 million in the prior quarter.
- The five-year high for Non-Current Debt was $13.8 million in Q4 2016, with the low at $625000.0 in Q4 2018.
- Historically, Non-Current Debt has averaged $7.5 million across 3 years, with a median of $7.6 million in 2017.
- Annual changes were most pronounced in 2017 — Non-Current Debt tumbled 45.3% — and 2018, when it tumbled 91.73%.
- Anaptysbio's Non-Current Debt stood at $13.8 million in 2016, then plunged by 45.3% to $7.6 million in 2017, then plunged by 91.73% to $625000.0 in 2018.
- The last three Non-Current Debt figures came in at $625000.0 (Q4 2018), $2.4 million (Q3 2018), and $4.1 million (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 625,000.00 |
| Dec 31, 2018 | 625,000.00 |
| Sep 30, 2018 | 2.41 Mn |
| Sep 30, 2018 | 2.41 Mn |
| Jun 30, 2018 | 4.12 Mn |
| Jun 30, 2018 | 4.12 Mn |
| Mar 31, 2018 | 5.83 Mn |
| Mar 31, 2018 | 5.83 Mn |
| Dec 31, 2017 | 7.55 Mn |
| Dec 31, 2017 | 7.55 Mn |
| Sep 30, 2017 | 9.27 Mn |
| Sep 30, 2017 | 9.27 Mn |
| Jun 30, 2017 | 10.99 Mn |
| Jun 30, 2017 | 10.99 Mn |
| Mar 31, 2017 | 12.71 Mn |
| Mar 31, 2017 | 12.71 Mn |
| Dec 31, 2016 | 13.81 Mn |
| Dec 31, 2016 | 13.81 Mn |